Clinical Trial Update: Rifaximin Treatment in Bloating Predominant Functional Bowel Disorders [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating rifaximin for bloating-predominant functional bowel disorders is listed as not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation
• Functional Gastrointestinal Disorder
• Irritable Bowel Syndrome

Drugs mentioned

• Rifaximin (rifaximin)

Snippet

Sponsor: Mahidol University | Conditions: Bloating, Rifaximin | Phase 3 | Status: NOT_YET_RECRUITING